Brucella abortus, S-19 vaccine was inoculated sub cutaneously in three groups, each comprising of 10 Nili-Ravi buffaloes using full (2.5 ml), hall and one quarter of the recommended dose. The serum analysis revealed non-significant (P>0.05) difference in the protection afforded by different dose levels of Brucella abortus, S-19 vaccine. More rapid sero conversion resulted from various reduced doses of vaccine compared with the standard full dose.